Trial reportMedical science monitor : international medical journal of experimental and clinical research2026
Mulberry Twig Alkaloids Combined With Insulin Infusion: Effects on Blood Glucose Variability in Type 2 Diabetes.
Trial report in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Glycemic variability is increasingly recognized as an important contributor to the development of diabetes-related complications in patients with type 2 diabetes mellitus (T2DM). Continuous subcutaneous insulin infusion (CSII) is effective in improving glycemic control; however, fluctuations in blood glucose can persist. Mulberry twig alkaloids (MTA), a traditional Chinese medicine component with hypoglycemic properties, have shown potential benefits in regulating glucose metabolism. This study aimed to evaluate whether MTA combined with CSII could further improve glycemic variability and symptoms recognized by traditional Chinese medicine (TCM) in patients with T2DM. MATERIAL AND METHODS Sixty hospitalized patients with T2DM were randomly assigned to a control group (CSII alone, n=30) or an MTA group (MTA tablets plus CSII, n=30). Flash glucose monitoring was used to assess glycemic variability indicators, including mean blood glucose (MBG), standard deviation of blood glucose (SDBG), coefficient of variation (CV), mean amplitude of glycemic excursions (MAGE), mean of daily differences (MODD), time in range (TIR, 3.9-10 mmol/L), time above range (TAR), and time below range (TBR) over 14 days. TCM symptom scores were evaluated before and after treatment. RESULTS After 14 days, MODD, MAGE, TAR, and TBR were significantly lower in the MTA group compared with the control group (all P<0.05), while TIR was significantly higher (P<0.01). Additionally, the TCM symptom score was markedly reduced in the MTA group compared with the control group (P<0.05). CONCLUSIONS Our findings suggested that CSII combined with mulberry twig alkaloids can improve blood glucose variability and relive TCM symptoms in T2DM patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.